Phase 0 1 trial
Phase 0
NCT04984330 Dec 2021 → Jun 2023 AL amyloidosis Weill Medical College of Cornell University
Withdrawn
No outcome recorded
Phase 1 42 trials
Phase 1
NCT07200102 Mar 2026 → Apr 2029 expected plasma cell myeloma Washington University School of Medicine
Recruiting
No outcome recorded
Phase 1
NCT07094464 Jun 2025 → Jun 2027 expected acute myeloid leukemia , disease related to hematopoietic stem cell transplant Daihong Liu
Active not recruiting
No outcome recorded
Phase 1
NCT06225310 Aug 2024 → Apr 2027 expected plasma cell myeloma Oncotherapeutics
Recruiting
No outcome recorded
Phase 1
NCT05952687 Mar 2024 → Sep 2025 atypical teratoid rhabdoid tumor St. Jude Children's Research Hospital
Withdrawn
No outcome recorded
Phase 1
NCT05354362 Mar 2022 → Feb 2023 relapsed/refractory diffuse large B-cell lymphoma Antengene Corporation
Terminated
No outcome recorded
Phase 1
NCT05201118 Jan → Dec 2022 plasma cell myeloma Chunrui Li
Unknown
No outcome recorded
Phase 1
NCT04898894 Nov 2021 → Jul 2023 overdue acute leukemia of ambiguous lineage St. Jude Children's Research Hospital
Active not recruiting
No outcome recorded
Phase 1
NCT05093608 Nov 2021 → Oct 2022 hepatocellular carcinoma H. Lee Moffitt Cancer Center and Research Institute
Terminated
No outcome recorded
Phase 1
NCT04811196 Mar 2021 → May 2025 endometrial stromal tumor , leiomyosarcoma , malignant peripheral nerve sheath tumor University Health Network, Toronto
Completed
No outcome recorded
Phase 1
NCT04850755 Mar 2021 → Mar 2025 high grade malignant neoplasm , metastatic malignant neoplasm National University Hospital, Singapore
Completed
No outcome recorded
Phase 1
NCT04640779 Feb 2021 → Nov 2025 Hodgkins lymphoma , histiocytic and dendritic cell neoplasm , non-Hodgkin lymphoma , plasma cell myeloma Mayo Clinic
Completed
No outcome recorded
Phase 1
NCT04519476 Nov 2020 → Dec 2023 refractory plasma cell neoplasm Oncotherapeutics
Unknown
No outcome recorded
Phase 1
NCT03880123 Nov 2020 Ewing sarcoma , alveolar soft part sarcoma , liposarcoma , malignant peripheral nerve sheath tumor Matthew Ingham
Withdrawn
No outcome recorded
Phase 1
NCT04595994 Sep 2020 → Nov 2025 soft tissue sarcoma Spanish Group for Research in Sarcomas
Unknown
No outcome recorded
Phase 1
NCT04216329 Jul 2020 → Sep 2023 overdue gliosarcoma National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 1
NCT03955783 Jun 2019 → Sep 2024 acute myeloid leukemia , diffuse large B-cell lymphoma Sanjay Mohan
Completed
No outcome recorded
Phase 1
NCT03661515 Jul 2018 → Jul 2019 acute myeloid leukemia PETHEMA Foundation
Completed
No outcome recorded
Phase 1
NCT03042819 May 2017 → Nov 2019 soft tissue sarcoma University Health Network, Toronto
Completed
No outcome recorded
Phase 1
NCT02741388 Oct 2016 → Sep 2021 B-cell neoplasm The Lymphoma Academic Research Organisation
Completed
No outcome recorded
Phase 1
NCT03212937 Jul 2016 → Nov 2020 peripheral T-cell lymphoma, not otherwise specified National Cancer Centre, Singapore
Completed
No outcome recorded
Phase 1
NCT02831686 Jul 2016 → Nov 2020 plasma cell myeloma , refractory plasma cell neoplasm Memorial Sloan Kettering Cancer Center
Completed
No outcome recorded
Phase 1
NCT02471911 Dec 2015 → Oct 2019 diffuse large B-cell lymphoma Weill Medical College of Cornell University
Completed
No outcome recorded
Phase 1
NCT02323880 Oct 2015 → Sep 2022 glioblastoma , grade III glioma , lymphoma , primary brain neoplasm Children's Oncology Group
Completed
No outcome recorded
Phase 1
NCT02573363 Oct 2015 → Jan 2018 acute myeloid leukemia University of Chicago
Completed
No outcome recorded
Phase 1
NCT02485535 Sep 2015 → Feb 2018 acute myeloid leukemia , myelodysplastic syndrome University of Chicago
Completed
No outcome recorded
Phase 1
NCT02419495 Jun 2015 → Sep 2024 cutaneous melanoma , fallopian tube carcinoma , metastatic malignant neoplasm , metastatic melanoma +5 M.D. Anderson Cancer Center
Terminated
No outcome recorded
Phase 1
NCT02403310 Jun 2015 → Sep 2016 acute myeloid leukemia by FAB classification H. Lee Moffitt Cancer Center and Research Institute
Completed
No outcome recorded
Phase 1
NCT02303392 Jun 2015 → Apr 2022 chronic lymphocytic leukemia/small lymphocytic lymphoma , diffuse large B-cell lymphoma , mantle cell lymphoma , prolymphocytic leukemia Jennifer Woyach
Completed
No outcome recorded
Phase 1
NCT02299518 May 2015 → Mar 2018 acute myeloid leukemia with 11q23 abnormalities , acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22) , acute myeloid leukemia with t(8;21)(q22;q22) translocation , acute promyelocytic leukemia Alice Mims
Completed
No outcome recorded
Phase 1
NCT02384850 Mar 2015 → Mar 2017 colorectal neoplasm GSO Global Clinical Research BV
Terminated
No outcome recorded
Phase 1
NCT02283359 Dec 2014 → Dec 2015 esophageal cancer , gastric cancer H. Lee Moffitt Cancer Center and Research Institute
Terminated
No outcome recorded
Phase 1
NCT02137356 Dec 2014 → Jun 2017 rectal neoplasm Sheba Medical Center
Unknown
No outcome recorded
Phase 1
NCT02269293 Oct 2014 → Apr 2021 endometrial cancer , ovarian cancer Memorial Sloan Kettering Cancer Center
Completed
No outcome recorded
Phase 1
NCT02120222 Aug 2014 → Apr 2018 melanoma Kari Kendra
Completed
No outcome recorded
Phase 1
NCT02212561 Aug 2014 → Dec 2015 acute lymphoblastic leukemia , mixed phenotype acute leukemia , myelodysplastic syndrome St. Jude Children's Research Hospital
Completed
No outcome recorded
Phase 1
NCT02199665 Jun 2014 → Oct 2025 plasma cell myeloma University of Chicago
Completed
No outcome recorded
Phase 1
NCT02093403 Mar 2014 → Nov 2016 acute myeloid leukemia Bhavana Bhatnagar
Completed
No outcome recorded
Phase 1
NCT02091245 Mar 2014 → Feb 2018 overdue blast phase chronic myelogenous leukemia, BCR-ABL1 positive , childhood acute lymphoblastic leukemia , mixed phenotype acute leukemia Dana-Farber Cancer Institute
Active not recruiting
No outcome recorded
Phase 1
NCT02078349 Feb 2014 → Mar 2020 cancer National University Hospital, Singapore
Completed
No outcome recorded
Phase 1
NCT01896505 Jul 2013 → Oct 2016 sarcoma Karyopharm Therapeutics Inc
Completed
No outcome recorded
Phase 1
NCT01607892 Jul 2012 → Oct 2015 hematopoietic and lymphoid cell neoplasm Karyopharm Therapeutics Inc
Completed
No outcome recorded
Phase 1
NCT01607905 Jun 2012 → Mar 2016 cancer Karyopharm Therapeutics Inc
Completed
No outcome recorded
Show 32 more trials Phase 1/2 38 trials
Phase 1/2
NCT07706959 Jul 2026 → Jan 2028 expected peripheral T-cell lymphoma, not otherwise specified Ruijin Hospital
Not yet recruiting
No outcome recorded
Phase 1/2
NCT07479979 Jul 2026 → Jul 2027 expected plasma cell myeloma Natalie Callander
Recruiting
No outcome recorded
Phase 1/2
NCT06966154 May 2025 → May 2027 expected T-cell and NK-cell neoplasm , extranodal nasal NK/T cell lymphoma Fudan University
Recruiting
No outcome recorded
Phase 1/2
NCT06559553 Sep 2024 → Dec 2026 expected T-cell and NK-cell neoplasm Mingzhi Zhang
Recruiting
No outcome recorded
Phase 1/2
NCT06556199 Aug 2024 → Aug 2026 overdue primary central nervous system lymphoma Second Affiliated Hospital, School of Medicine, Zhejiang University
Recruiting
No outcome recorded
Phase 1/2
NCT06552559 May 2024 → Dec 2028 expected B-cell non-Hodgkin lymphoma , metastatic malignant neoplasm in the brain Samsung Medical Center
Recruiting
No outcome recorded
Phase 1/2
NCT06239272 Mar 2024 → Jun 2034 expected angiosarcoma , extraosseous osteosarcoma , fibrosarcoma , histiocytoma, Angiomatoid fibrous +3 St. Jude Children's Research Hospital
Recruiting
No outcome recorded
Phase 1/2
NCT05975944 Sep 2023 small cell lung carcinoma Tianjin Medical University Cancer Institute and Hospital
Unknown
No outcome recorded
Phase 1/2
NCT05698147 Aug 2023 → Jun 2026 overdue central nervous system cancer Tong Chen, MD
Recruiting
No outcome recorded
Phase 1/2
NCT06449482 May 2023 → Mar 2025 acute myeloid leukemia Institute of Hematology & Blood Diseases Hospital, China
Terminated
No outcome recorded
Phase 1/2
NCT05432804 Mar 2023 → Jun 2027 expected IDH-wildtype glioblastoma National Cancer Institute (NCI)
Recruiting
No outcome recorded
Phase 1/2
NCT05675813 Feb 2023 → Jul 2026 overdue peripheral T-cell lymphoma, not otherwise specified Ruijin Hospital
Recruiting
No outcome recorded
Phase 1/2
NCT05577364 Nov 2022 → Dec 2024 diffuse large B-cell lymphoma Sun Yat-sen University
Unknown
No outcome recorded
Phase 1/2
NCT05498636 Oct 2022 → Jul 2025 diffuse large B-cell lymphoma The Affiliated Hospital of Qingdao University
Unknown
No outcome recorded
Phase 1/2
NCT05422027 Jul 2022 → Jun 2025 plasma cell myeloma Xia Zhongjun
Unknown
No outcome recorded
Phase 1/2
NCT05099003 May 2022 → Jun 2027 expected malignant glioma National Cancer Institute (NCI)
Recruiting
No outcome recorded
Phase 1/2
NCT05265975 Apr 2022 → Dec 2024 diffuse large B-cell lymphoma , indolent B-cell non-Hodgkin lymphoma Antengene Corporation
Terminated
No outcome recorded
Phase 1/2
NCT04891744 Jul 2021 → Dec 2024 plasma cell myeloma Li Zheng
Unknown
No outcome recorded
Phase 1/2
NCT04764942 May 2021 → May 2026 overdue plasma cell myeloma Mayo Clinic
Active not recruiting
No outcome recorded
Phase 1/2
NCT04856189 Apr 2021 → Jan 2024 urothelial carcinoma Mamta Parikh
Terminated
No outcome recorded
Phase 1/2
NCT05035745 Mar 2021 → Nov 2027 expected refractory malignant neoplasm , triple-negative breast carcinoma National University Hospital, Singapore
Recruiting
No outcome recorded
Phase 1/2
NCT04607772 Nov 2020 → Dec 2025 diffuse large B-cell lymphoma Karyopharm Therapeutics Inc
Withdrawn
No outcome recorded
Phase 1/2
NCT04425070 Aug 2020 → Dec 2025 mature T-cell and NK-cell non-Hodgkin lymphoma , peripheral T-cell lymphoma, not otherwise specified Antengene Corporation
Terminated
No outcome recorded
Phase 1/2
NCT04421378 Jun 2020 → Jul 2023 glioblastoma Karyopharm Therapeutics Inc
Terminated
No outcome recorded
Phase 1/2
NCT04138381 Aug 2019 → Apr 2023 gastrointestinal stromal tumor , poisoning , soft tissue sarcoma , substance abuse Spanish Group for Research in Sarcomas
Unknown
No outcome recorded
Phase 1/2
NCT03732703 Apr 2019 → Dec 2024 refractory plasma cell neoplasm Multiple Myeloma Research Consortium
Completed
No outcome recorded
Phase 1/2
NCT03095612 Mar 2018 → Nov 2022 non-small cell lung carcinoma University of Texas Southwestern Medical Center
Terminated
No outcome recorded
Phase 1/2
NCT02780609 Jul 2017 → Feb 2021 plasma cell myeloma H. Lee Moffitt Cancer Center and Research Institute
Completed
No outcome recorded
Phase 1/2
NCT03147885 Jun 2017 → Dec 2027 expected MALT lymphoma , Waldenstrom macroglobulinemia , diffuse large B-cell lymphoma , follicular lymphoma +1 Barbara Ann Karmanos Cancer Institute
Active not recruiting
No outcome recorded
Phase 1/2
NCT02530476 Dec 2015 → Apr 2019 acute myeloid leukemia M.D. Anderson Cancer Center
Completed
No outcome recorded
Phase 1/2
NCT02343042 Oct 2015 → Apr 2027 expected plasma cell myeloma Karyopharm Therapeutics Inc
Recruiting
No outcome recorded
Phase 1/2
NCT02536495 Sep 2015 → Dec 2018 squamous cell lung carcinoma Erin Bertino
Withdrawn
No outcome recorded
Phase 1/2
NCT02389543 Jul 2015 → Jan 2018 plasma cell myeloma Karyopharm Therapeutics Inc
Withdrawn
No outcome recorded
Phase 1/2
NCT02416908 Jun 2015 → Jun 2019 acute myeloid leukemia Washington University School of Medicine
Completed
No outcome recorded
Phase 1/2
NCT02367690 Jan → May 2015 ulcer of lower limbs Karyopharm Therapeutics Inc
Withdrawn
No outcome recorded
Phase 1/2
NCT02178436 Oct 2014 → Nov 2021 pancreatic acinar cell carcinoma , pancreatic ductal adenocarcinoma Mohammed Najeeb Al Hallak
Completed
No outcome recorded
Phase 1/2
NCT02186834 Sep 2014 → Nov 2017 plasma cell myeloma H. Lee Moffitt Cancer Center and Research Institute
Completed
No outcome recorded
Phase 1/2
NCT05177276 Sep 2014 → Sep 2015 cancer Martin Gutierrez
Withdrawn
No outcome recorded
Show 28 more trials Phase 2 83 trials
Phase 2
NCT07626021 Jul → Aug 2026 overdue myeloproliferative neoplasm Zhongshan Hospital (Xiamen), Fudan University
Not yet recruiting
No outcome recorded
Phase 2
NCT07554482 May 2026 → Dec 2027 expected mature T-cell and NK-cell non-Hodgkin lymphoma Beijing Tongren Hospital
Not yet recruiting
No outcome recorded
Phase 2
NCT07574528 May 2026 → Mar 2028 expected extranodal nasal NK/T cell lymphoma Sun Yat-sen University
Not yet recruiting
No outcome recorded
Phase 2
NCT07447817 May 2026 → May 2030 expected myelofibrosis John Mascarenhas
Not yet recruiting
No outcome recorded
Phase 2
NCT07523737 Apr 2026 → Mar 2028 expected diffuse large B-cell lymphoma , primary central nervous system lymphoma Beijing Tongren Hospital
Recruiting
No outcome recorded
Phase 2
NCT07405255 Jan 2026 → Dec 2027 expected lymphoma Ruijin Hospital
Not yet recruiting
No outcome recorded
Phase 2
NCT07276698 Dec 2025 → Dec 2029 expected mature T-cell and NK-cell non-Hodgkin lymphoma Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Not yet recruiting
No outcome recorded
Phase 2
NCT07172412 Nov 2025 → Dec 2027 expected small cell lung carcinoma Tianjin Medical University Cancer Institute and Hospital
Not yet recruiting
No outcome recorded
Phase 2
NCT06822972 Aug 2025 → Dec 2026 expected plasma cell myeloma Duke University
Recruiting
No outcome recorded
Phase 2
NCT07204041 Aug 2025 → Aug 2027 expected Langerhans cell histiocytosis Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Active not recruiting
No outcome recorded
Phase 2
NCT07002099 Jun 2025 → Dec 2028 expected lymphoma Second Affiliated Hospital of Soochow University
Recruiting
No outcome recorded
Phase 2
NCT06900088 Apr → Oct 2025 overdue acute myeloid leukemia , chronic myelomonocytic leukemia , myelodysplastic syndrome Institute of Hematology & Blood Diseases Hospital, China
Not yet recruiting
No outcome recorded
Phase 2
NCT06813079 Apr 2025 → Feb 2028 expected pancreatic ductal adenocarcinoma University Health Network, Toronto
Recruiting
No outcome recorded
Phase 2
NCT06744894 Jan 2025 → Jan 2028 expected plasma cell myeloma Navy General Hospital, Beijing
Not yet recruiting
No outcome recorded
Phase 2
NCT06765928 Jan 2025 → Jan 2026 overdue acute myeloid leukemia , myelodysplastic syndrome Ruijin Hospital
Not yet recruiting
No outcome recorded
Phase 2
NCT06664970 Nov 2024 → Sep 2025 overdue myelodysplastic syndrome Peking Union Medical College Hospital
Enrolling by invitation
No outcome recorded
Phase 2
NCT06652139 Nov 2024 → Nov 2026 expected diffuse large B-cell lymphoma Ruijin Hospital
Not yet recruiting
No outcome recorded
Phase 2
NCT06573151 Sep 2024 → Jul 2027 expected lymphoma Ruijin Hospital
Not yet recruiting
No outcome recorded
Phase 2
NCT06573138 Sep 2024 → Jul 2027 expected extranodal nasal NK/T cell lymphoma Ruijin Hospital
Not yet recruiting
No outcome recorded
Phase 2
NCT06517511 Aug 2024 → Jan 2027 expected diffuse large B-cell lymphoma Sun Yat-sen University
Recruiting
No outcome recorded
Phase 2
NCT06169215 Jul 2024 → Sep 2026 expected plasma cell myeloma National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 2
NCT05980806 Apr 2024 → Jun 2027 expected myelofibrosis , thrombocytopenia Karyopharm Therapeutics Inc
Recruiting
No outcome recorded
Phase 2
NCT05820763 Jan 2024 → Jan 2027 amyloidosis , plasma cell myeloma Washington University School of Medicine
Withdrawn
No outcome recorded
Phase 2
NCT07437170 Jan 2024 → Dec 2027 expected childhood acute myeloid leukemia The Children's Hospital of Zhejiang University School of Medicine
Active not recruiting
No outcome recorded
Phase 2
NCT05983276 Nov 2023 → Aug 2030 expected ovarian cancer Loyola University
Recruiting
No outcome recorded
Phase 2
NCT06062641 Oct 2023 → Apr 2024 overdue B-cell non-Hodgkin lymphoma Ruijin Hospital
Not yet recruiting
No outcome recorded
Phase 2
NCT06114004 Sep 2023 → May 2026 overdue soft tissue sarcoma Asociación Europea y Latinoamericana SELNET para la Investigación en Sarcomas
Recruiting
No outcome recorded
Phase 2
NCT05597345 Aug 2023 → Oct 2024 overdue smoldering plasma cell myeloma University of Rochester
Recruiting
No outcome recorded
Phase 2
NCT05985161 Aug 2023 → Aug 2029 expected Wilms tumor , malignant peripheral nerve sheath tumor , rhabdoid tumor Memorial Sloan Kettering Cancer Center
Recruiting
No outcome recorded
Phase 2
NCT05833893 May 2023 → Dec 2025 overdue mature T-cell and NK-cell non-Hodgkin lymphoma Chinese PLA General Hospital
Recruiting
No outcome recorded
Phase 2
NCT05736978 Mar 2023 → Mar 2025 overdue acute myeloid leukemia Shanghai Tong Ren Hospital
Recruiting
No outcome recorded
Phase 2
NCT05530421 Mar 2023 → Mar 2028 expected refractory plasma cell neoplasm University of Miami
Recruiting
No outcome recorded
Phase 2
NCT05951855 Mar 2023 → Sep 2024 acute myeloid leukemia The First Affiliated Hospital of Soochow University
Unknown
No outcome recorded
Phase 2
NCT05736965 Feb 2023 → Mar 2025 overdue acute myeloid leukemia Shanghai Tong Ren Hospital
Recruiting
No outcome recorded
Phase 2
NCT04756401 Dec 2022 → Sep 2024 overdue plasma cell myeloma Academic and Community Cancer Research United
Active not recruiting
No outcome recorded
Phase 2
NCT05478993 Oct 2022 → Jul 2024 plasma cell myeloma Peking University People's Hospital
Unknown
No outcome recorded
Phase 2
NCT05333458 Aug 2022 → May 2027 expected alveolar soft part sarcoma National Cancer Institute (NCI)
Recruiting
No outcome recorded
Phase 2
NCT05974085 Aug 2022 → Dec 2023 high-grade B-cell lymphoma double-hit/triple-hit Zhejiang Cancer Hospital
Unknown
No outcome recorded
Phase 2
NCT05422066 Jul 2022 → Jul 2025 diffuse large B-cell lymphoma germinal center B-cell type Li Zhiming
Unknown
No outcome recorded
Phase 2
NCT05900882 Jul 2022 → Aug 2025 overdue plasma cell myeloma The First Affiliated Hospital with Nanjing Medical University
Recruiting
No outcome recorded
Phase 2
NCT05170789 Apr 2022 plasma cell myeloma Tulane University School of Medicine
Withdrawn
No outcome recorded
Phase 2
NCT05322330 Feb 2022 → Feb 2024 B-cell non-Hodgkin lymphoma The First Affiliated Hospital of Soochow University
Completed
No outcome recorded
Phase 2
NCT04941937 Jan 2022 → Dec 2025 plasma cell myeloma Juan Du
Unknown
No outcome recorded
Phase 2
NCT04843579 Dec 2021 → Nov 2022 plasma cell myeloma Weill Medical College of Cornell University
Terminated
No outcome recorded
Phase 2
NCT04925193 Nov 2021 → Aug 2024 overdue plasma cell myeloma University of Colorado, Denver
Active not recruiting
No outcome recorded
Phase 2
NCT04782687 Sep 2021 → May 2026 overdue plasma cell myeloma US Oncology Research
Active not recruiting
No outcome recorded
Phase 2
NCT04717700 Aug 2021 → Aug 2025 overdue plasma cell myeloma Ida Bruun Kristensen
Active not recruiting
No outcome recorded
Phase 2
NCT04998760 Aug 2021 → Jan 2024 endometrial cancer , ovarian cancer Qi Zhou
Unknown
No outcome recorded
Phase 2
NCT04854434 Jun 2021 → Jun 2022 colorectal cancer Karyopharm Therapeutics Inc
Terminated
No outcome recorded
Phase 2
NCT04877275 May 2021 → Dec 2024 plasma cell myeloma Chunyan Sun, MD
Unknown
No outcome recorded
Phase 2
NCT04768881 May 2021 → Sep 2023 —
Karyopharm Therapeutics Inc
Terminated
No outcome recorded
Phase 2
NCT04562870 Mar 2021 → Sep 2026 expected myelofibrosis Karyopharm Therapeutics Inc
Active not recruiting
No outcome recorded
Phase 2
NCT04661137 Mar 2021 → Feb 2027 plasma cell myeloma Hackensack Meridian Health
Suspended
No outcome recorded
Phase 2
NCT04414475 Jul 2020 → Jan 2028 expected refractory plasma cell neoplasm Karyopharm Therapeutics Inc
Recruiting
No outcome recorded
Phase 2
NCT04355676 Apr → Aug 2020 COVID-19 Karyopharm Therapeutics Inc
Withdrawn
No outcome recorded
Phase 2
NCT04349098 Apr → Oct 2020 COVID-19 Karyopharm Therapeutics Inc
Completed
No outcome recorded
Phase 2
NCT03992339 Apr 2020 → May 2023 diffuse large B-cell lymphoma Antengene Corporation
Completed
No outcome recorded
Phase 2
NCT03944057 Sep 2019 → Feb 2022 refractory plasma cell neoplasm Antengene Corporation
Completed
No outcome recorded
Phase 2
NCT03627403 May 2019 → Aug 2023 myelofibrosis , primary myelofibrosis University of Utah
Terminated
No outcome recorded
Phase 2
NCT06212596 Jul 2018 → Oct 2022 refractory plasma cell neoplasm University of Leeds
Completed
No outcome recorded
Phase 2
NCT03589222 Jul 2018 → Aug 2026 overdue plasma cell myeloma PETHEMA Foundation
Active not recruiting
No outcome recorded
Phase 2
NCT03193437 Apr 2018 → Jul 2020 thymoma Georgetown University
Terminated
No outcome recorded
Phase 2
NCT02835222 Feb 2018 → Feb 2027 expected acute myeloid leukemia Wake Forest University Health Sciences
Active not recruiting
No outcome recorded
Phase 2
NCT03466827 Oct 2017 → Jul 2020 thymoma Morten Mau-Soerensen
Unknown
No outcome recorded
Phase 2
NCT03071276 Jan 2016 → Apr 2019 acute myeloid leukemia St. Jude Children's Research Hospital
Terminated
No outcome recorded
Phase 2
NCT02628704 Dec 2015 → Jun 2017 plasma cell myeloma Karyopharm Therapeutics Inc
Withdrawn
No outcome recorded
Phase 2
NCT02431351 Nov 2015 → Dec 2017 myelodysplastic syndrome Karyopharm Therapeutics Inc
Withdrawn
No outcome recorded
Phase 2
NCT02436707 Oct 2015 → Jun 2026 overdue lymphoma Canadian Cancer Trials Group
Active not recruiting
No outcome recorded
Phase 2
NCT02402764 Jul 2015 → Mar 2016 breast cancer H. Lee Moffitt Cancer Center and Research Institute
Completed
No outcome recorded
Phase 2
NCT02336815 May 2015 → Jul 2019 plasma cell myeloma Karyopharm Therapeutics Inc
Completed
No outcome recorded
Phase 2
NCT02351505 May → Dec 2015 small cell lung carcinoma Erin Bertino
Terminated
No outcome recorded
Phase 2
NCT02314247 Feb 2015 → Jan 2016 peripheral T-cell lymphoma, not otherwise specified , primary cutaneous T-cell lymphoma Karyopharm Therapeutics Inc
Terminated
No outcome recorded
Phase 2
NCT02138786 Nov 2014 → Aug 2016 Richter transformation Karyopharm Therapeutics Inc
Terminated
No outcome recorded
Phase 2
NCT02227251 Nov 2014 → Dec 2026 expected diffuse large B-cell lymphoma Karyopharm Therapeutics Inc
Active not recruiting
No outcome recorded
Phase 2
NCT02213133 Sep 2014 → Dec 2015 squamous cell carcinoma Karyopharm Therapeutics Inc
Terminated
No outcome recorded
Phase 2
NCT02215161 Sep 2014 → Feb 2017 hormone-resistant prostate carcinoma , metastatic prostate carcinoma , prostate adenocarcinoma University of California, San Francisco
Terminated
No outcome recorded
Phase 2
NCT02249091 Sep 2014 → Jul 2018 acute myeloid leukemia GSO Global Clinical Research BV
Completed
No outcome recorded
Phase 2
NCT02228525 Aug 2014 → Apr 2021 myelodysplastic syndrome Memorial Sloan Kettering Cancer Center
Completed
No outcome recorded
Phase 2
NCT02250885 Aug 2014 → Aug 2016 neuroendocrine carcinoma Gabrail Cancer Center Research
Completed
No outcome recorded
Phase 2
NCT02146833 May 2014 → Apr 2016 prostate cancer Karyopharm Therapeutics Inc
Terminated
No outcome recorded
Phase 2
NCT02025985 Apr 2014 → Jan 2017 cervical carcinoma , endometrial carcinoma , ovarian carcinoma Karyopharm Therapeutics Inc
Completed
No outcome recorded
Phase 2
NCT01986348 Mar 2014 → Jan 2020 glioblastoma Karyopharm Therapeutics Inc
Terminated
No outcome recorded
Phase 2
NCT02088541 Mar 2014 → Jan 2018 acute myeloid leukemia Karyopharm Therapeutics Inc
Completed
No outcome recorded
Show 73 more trials Phase 2/3 4 trials
Phase 2/3
NCT07369739 Jan 2026 → Jan 2027 expected Epstein-Barr virus infection , histiocytosis Beijing Friendship Hospital
Recruiting
No outcome recorded
Phase 2/3
NCT05822050 Jun 2023 → Dec 2024 —
The First Hospital of Jilin University
Unknown
No outcome recorded
Phase 2/3
NCT04442022 Sep 2020 → Dec 2026 expected diffuse large B-cell lymphoma Karyopharm Therapeutics Inc
Active not recruiting
No outcome recorded
Phase 2/3
NCT02606461 Jan 2016 → Oct 2020 dedifferentiated liposarcoma Karyopharm Therapeutics Inc
Completed
No outcome recorded
Phase 3 11 trials
Phase 3
NCT07138209 Nov 2025 → Dec 2027 expected refractory plasma cell neoplasm Qilu Pharmaceutical Co., Ltd.
Recruiting
No outcome recorded
Phase 3
NCT06613035 Sep 2024 → Sep 2027 expected acute myeloid leukemia Institute of Hematology & Blood Diseases Hospital, China
Not yet recruiting
No outcome recorded
Phase 3
NCT06158841 May 2024 → Dec 2027 expected plasma cell myeloma AbbVie
Recruiting
No outcome recorded
Phase 3
NCT05611931 Apr 2023 → Aug 2026 overdue endometrial cancer Karyopharm Therapeutics Inc
Active not recruiting
No outcome recorded
Phase 3
NCT05726110 Jan 2023 → Dec 2024 overdue acute myeloid leukemia Shanxi Bethune Hospital
Recruiting
No outcome recorded
Phase 3
NCT05028348 Apr 2022 → Mar 2026 overdue plasma cell myeloma European Myeloma Network B.V.
Active not recruiting
No outcome recorded
Phase 3
NCT04939142 Jul 2021 → Dec 2025 overdue refractory plasma cell neoplasm Antengene Corporation
Active not recruiting
No outcome recorded
Phase 3
NCT04562389 Mar 2021 → Feb 2026 overdue myelofibrosis Karyopharm Therapeutics Inc
Active not recruiting
No outcome recorded
Phase 3
NCT04534725 Dec 2020 → Nov 2022 COVID-19 , cancer , viral respiratory tract infection Peter MacCallum Cancer Centre, Australia
Completed
No outcome recorded
Phase 3
NCT03555422 Jan 2018 → Jan 2022 endometrial cancer Karyopharm Therapeutics Inc
Completed
No outcome recorded
Phase 3
NCT03110562 May 2017 → Feb 2020 plasma cell myeloma Karyopharm Therapeutics Inc
Completed
No outcome recorded
Show 1 more trial Phase 4 2 trials
Phase 4
NCT07264894 Dec 2025 → Dec 2027 expected mantle cell lymphoma Zhengzhou University
Not yet recruiting
No outcome recorded
Phase 4
NCT05786989 Feb 2023 → Mar 2024 diffuse large B-cell lymphoma Chongqing University Cancer Hospital
Unknown
No outcome recorded
Phase not applicable 7 trials
— NCT07632170 Nov 2026 → Oct 2027 expected myeloid neoplasm Bing Han
Not yet recruiting
No outcome recorded
— NCT07191431 Sep 2025 → Sep 2027 expected central nervous system non-hodgkin lymphoma Ruijin Hospital
Recruiting
No outcome recorded
— NCT06853678 Feb 2025 → Jul 2026 overdue small cell lung carcinoma Tianjin Medical University Cancer Institute and Hospital
Recruiting
No outcome recorded
— NCT07074470 Jan 2025 → Jan 2030 expected primary central nervous system lymphoma The First Affiliated Hospital of Soochow University
Recruiting
No outcome recorded
— NCT07236931 Jan 2025 → May 2026 acute myeloid leukemia Donghua Zhang
Completed
No outcome recorded
— NCT05805072 May 2023 → Jun 2024 acute myeloid leukemia The First Affiliated Hospital of Soochow University
Unknown
No outcome recorded
— NCT02069730 Jun 2014 → Jun 2023 metastatic malignant neoplasm , salivary gland cancer University Health Network, Toronto
Completed
No outcome recorded
Phase not stated 2 trials
— NCT03850704 — plasma cell myeloma Masonic Cancer Center, University of Minnesota
No longer available
No outcome recorded
— NCT07215832 — diffuse large B-cell lymphoma , endometrial cancer , myelofibrosis , neural glioblastoma +3 Karyopharm Therapeutics Inc
Available
No outcome recorded